Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Prophylactic Mastectomy and Genetic Testing: An Update

Shauna L. Houshmand
Craig T. Campbell
Sheri E. Briggs
Andrew W.J. McFadden
Toher AI-Tweigeri
ONF 2000, 27(10), 1537-1547 DOI:
Purpose/Objectives: To examine and discuss the pos­sible benefits and difficulties with recommending pro­phylactic mastectomy to BRCA1- and BRCA2-positive women. 
Data Sources: Published research articles, profes­sional review articles, textbooks. 
Data Synthesis: Women with BRCA1 and BRCA2 mu­tations face a much higher risk of developing breast cancer than the general population, with limited op­tions available for prevention. Prophylactic mastec­tomy has been shown to have a survival advantage in young women who carry BRCA1 and BRCA2 mutations. Challenges exist, however, in the use of prophylactic mastectomy and genetic testing. 
Conclusions: Methods of preventing breast cancer In BRCA1- and BRCA2-positive women currently are lim­ited to watch-and-wait surveillance, prophylactic mas­tectomy, and, perhaps, chemoprevention. Genetic 
testing and prophylactic mastectomy each present unique challenges while offering certain benefits as well. Recent studies have shown survival advantages to BRCA1- and BRCA2-positive women who undergo pro­phylactic mastectomy. 
Implications for Nursing Practice: Nurses need to be aware of the complex Issues surrounding testing for BRCA1 and BRCA2 mutations and prophylactic mas­tectomy to be able to provide current information to patients and assist in decision making. 

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or